NCT03328533View on ClinicalTrials.gov

Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

November 10, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

May 5, 2018

Conditions
Cesarean Section ComplicationsSpinal Anesthesia
Interventions
DRUG

Phenylephrine

Phenylephrine variable infusion with a starting rate of 0.75 mcg/Kg/min.

DRUG

Norepinephrine

Norepinephrine bitartrate variable infusion with a starting rate of 0.1 mcg/Kg/min (equivalent to norepinephrine base of 0.05 mcg/Kg/min).

DRUG

Bupivacaine

Bupivacaine will be injected in the subarachnoid space with a dose of 10 mg.

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03328533 - Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean Delivery | Biotech Hunter | Biotech Hunter